Volume 16, Number 10—October 2010
Letter
Underlying Medical Conditions and Hospitalization for Pandemic (H1N1) 2009, Japan
Table
Patient characteristic | Underlying medical conditions† |
No underlying medical conditions‡ |
RR | AR | |||
---|---|---|---|---|---|---|---|
No. (%) patients | Incidence/100,000§ | No. (%) patients | Incidence/100,000§ | ||||
Age group, y | |||||||
0–4 | 648 (22.1) | 195.2 | 2,285 (77.9) | 45.2 | 4.3 | 150.0 | |
5–9 | 1,848 (32.6) | 814.1 | 3,822 (67.4) | 69.4 | 11.7 | 744.7 | |
10–14 | 763 (35.2) | 573.7 | 1,406 (64.8) | 24.0 | 23.9 | 549.6 | |
15–19 | 173 (38.9) | 219.0 | 272 (61.1) | 4.5 | 48.4 | 214.5 | |
20–29 | 110 (43.8) | 53.9 | 141 (56.2) | 1.0 | 54.9 | 52.9 | |
30–39 | 105 (49.8) | 28.5 | 106 (50.2) | 0.6 | 48.4 | 27.9 | |
40–49 | 125 (61.6) | 21.6 | 78 (38.4) | 0.5 | 43.5 | 21.1 | |
50–59 | 176 (76.9) | 12.8 | 53 (23.1) | 0.3 | 38.3 | 12.5 | |
60–69 | 148 (77.5) | 6.7 | 43 (22.5) | 0.3 | 24.0 | 6.5 | |
>70 |
324 (81.0) |
8.2 |
76 (19.0) |
0.5 |
17.9 |
7.8 |
|
Gender¶ | |||||||
M | 2,857 (35.3) | NA | 5,236 (64.7) | NA | |||
F |
1,563 (33.9) |
NA |
3,046 (66.1) |
NA |
|||
*RR, relative risk for hospitalization; AR, attributable risk for hospitalization; NA, not available. Medical conditions defined as chronic respiratory diseases, chronic cardiovascular diseases, chronic renal diseases, chronic liver diseases, neurologic diseases, hematologic diseases, diabetes, and immunosuppression (including malignant neoplasm) and chronic childhood diseases. †n = 4,420 (43.8%); 83 patients died. ‡n = 8,282 (65.2%); 27 patients died. §Incidence = no. case-patients with pandemic (H1N1) 2009 virus infection and a particular medical condition/total population having the same medical condition (e.g., population 0–4 years of age with medical condition). ¶p value for difference in gender was 0.11, obtained by χ2 test (2-sided) for testing the null hypothesis. |
Page created: September 08, 2011
Page updated: September 08, 2011
Page reviewed: September 08, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.